跳至主要内容
临床试验/EUCTR2013-001229-15-ES
EUCTR2013-001229-15-ES进行中(未招募)1 期

The efficacy of oral and intravenous administration of sodium chloride in the prophylaxis of nephropathy induced by iodinated contrasts in outpatients

Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal0 个研究点目标入组 266 人开始时间: 2013年6月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
266

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients will undergo performing contrast CT, as indicated by clinical practice, and after being informated, agree to participate and sign the written consent to participate in the study , and meet the following criteria:
  • Age over 65 years
  • One of the following risk factors for NIC: diabetes mellitus, stable heart failure or kidney failure (estimated glomerular filtration rate calculated by the MDRD-4 between 30 and 60 ml / min)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 266

排除标准

  • Glomerular filtration rate below 30 ml / min.
  • Presence of hypokalemia (serum potassium less than 3.5 mEq / L).
  • Other procedures with intravenous contrast in the 15 previous days.
  • Administration of nephrotoxic drugs (NSAIDs, aminoglycosides and / or potentially nephrotoxic chemotherapy) in the previous72 hours, or after the treatment.

研究者

发起方
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal

相似试验